Funders › MD › National Foundation for Cancer Research › 2018
Grants paid by National Foundation for Cancer Research, tax year 2018
EIN 04-2531031 · Rockville, MD · Form 990, Schedule I · NTEE H30
In tax year 2018, National Foundation for Cancer Research (EIN 04-2531031) reported 23 grants paid totaling $3,481,556. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2018
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2018 | Global Coalition for Adaptive Research Inc Lexington, MA | A | $562,688 | paid | RESEARCH CONTRACTS | 201902489349301250 |
| 2018 | Tvardi Therapeutics Inc Houston, TX | A | $500,000 | paid | TRANSLATIONAL | 201902489349301250 |
| 2018 | Massachusetts General Hospital Boston, MA | A | $312,790 + $44,987 non-cash | paid | RESEARCH CONTRACTS | 201902489349301250 |
| 2018 | Invamet Therapeutics LLC Wilmington, DE | A | $225,000 | paid | TRANSLATIONAL | 201902489349301250 |
| 2018 | Interleukin Combinatorial Therapies Inc Wilmington, DE | A | $200,000 | paid | TRANSLATIONAL | 201902489349301250 |
| 2018 | Stromatis Pharma LLC Athens, GA | A | $125,000 | paid | TRANSLATIONAL | 201902489349301250 |
| 2018 | Nonpariel Biotechnologies LLC Mclean, VA | A | $125,000 | paid | TRANSLATIONAL | 201902489349301250 |
| 2018 | Wake Forest University Health Sciences Winstonsalem, NC | A | $113,645 + $20,000 non-cash | paid | RESEARCH CONTRACTS | 201902489349301250 |
| 2018 | Silcsbio LLC Baltimore, MD | A | $100,000 | paid | TRANSLATIONAL | 201902489349301250 |
| 2018 | Yiviva Inc New York, NY | A | $100,000 | paid | TRANSLATIONAL | 201902489349301250 |
| 2018 | Oncokids Biosciences Brookline, MA | A | $100,000 | paid | TRANSLATIONAL | 201902489349301250 |
| 2018 | University of Pennsylvania Philadelphia, PA | A | $100,000 + $15,000 non-cash | paid | RESEARCH CONTRACTS | 201902489349301250 |
| 2018 | Virginia Commonwealth University Richmond, VA | A | $100,000 + $20,000 non-cash | paid | RESEARCH CONTRACTS | 201902489349301250 |
| 2018 | Dana-Farber Cancer Institute Boston, MA | A | $100,000 | paid | RESEARCH CONTRACTS | 201902489349301250 |
| 2018 | University of Maryland Baltimore, MD | A | $100,000 | paid | RESEARCH CONTRACTS | 201902489349301250 |
| 2018 | The Scripps Research Institute La Jolla, CA | A | $100,000 | paid | RESEARCH CONTRACTS | 201902489349301250 |
| 2018 | The Translational Genomics Research Institute Phoenix, AZ | A | $98,413 | paid | RESEARCH CONTRACTS | 201902489349301250 |
| 2018 | Albert Einstein College of Medicine Bronx, NY | A | $93,652 + $47,159 non-cash | paid | RESEARCH CONTRACTS | 201902489349301250 |
| 2018 | Scottsdale Healthcare Corp Scottsdale, AZ | A | $87,800 | paid | CANCER HOTLINE | 201902489349301250 |
| 2018 | Case Western Reserve University Cleveland, OH | A | $86,437 | paid | RESEARCH CONTRACTS | 201902489349301250 |
| 2018 | Kumc Research Institute Inc Kansas City, KS | A | $86,242 | paid | RESEARCH CONTRACTS | 201902489349301250 |
| 2018 | University of Texas - Md Anderson Cancer Center Houston, TX | A | $39,889 | paid | RESEARCH CONTRACTS | 201902489349301250 |
| 2018 | Vitanova Biomedical Inc Kerrville, TX | A | $25,000 | paid | TRANSLATIONAL | 201902489349301250 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.